Coulter C H, Fabius R, Hecksher V, Darling H
UltraLink, LLC, Costa Mesa, CA, USA.
Manag Care Q. 1998 Winter;6(1):8-15.
HMOs have sought to enhance the provision of organ and tissue transplantation services for their members through centers of excellence (COE) programs. Such programs initially assess and subsequently monitor the medical centers offered as part of such programs on the basis of procedure volumes and outcomes, as well as the experience of the transplantation surgeons. Purchasers rely on the presence of COE programs to assure their beneficiaries of access to appropriate care in the event that a need for transplantation arises, but little comparative literature exists on these HMO programs. One purchaser assessed the COE programs offered by 89 HMOs serving its beneficiaries, based on the criteria developed on its behalf by the medical directors of six different health systems and reviewed by HMO and academic medical center personnel. 57 (75 percent) met these criteria, and the implications for HMOs, medical centers, beneficiaries, and other purchasers are explored.
健康维护组织（HMOs）试图通过卓越中心（COE）项目，加强为其成员提供器官和组织移植服务。此类项目首先会对作为该项目一部分提供的医疗中心进行评估，随后根据手术量、治疗结果以及移植外科医生的经验对这些医疗中心进行监测。购买者依靠卓越中心项目，确保其受益人在需要进行移植时能够获得适当的护理，但关于这些健康维护组织项目的比较文献很少。一家购买者根据六个不同医疗系统的医学主任代表其制定并经健康维护组织和学术医疗中心人员审核的标准，评估了为其受益人服务的89家健康维护组织提供的卓越中心项目。57家（75%）符合这些标准，并探讨了对健康维护组织、医疗中心、受益人和其他购买者的影响。
